Irinotecan Market By Type (Irinotecan Hydrochloride Injection 40mg, Irinotecan Hydrochloride Injection 100mg, Others), By Application (Colon Cancer, Rectal Cancer) - Industry Size, Growth, Share And Forecast To 2026
Irinotecan is an antineoplastic enzyme inhibitor that primarily finds application in the treatment of Cancer especially colorectal cancer. The global Irinotecan demand is primarily driven due to increasing incidences of colorectal cancer globally coupled with increasing research and development on biological and targeted drug therapies for cancer and increasing research and development of novel approaches to cancer treatment. Global Irinotecan market is expected to show a modest growth over the forecast period growing at with a CAGR of 12% over the forecast period of 2019 to 2026. Furthermore, the onset of personalized medicine approach along with is offering huge growth opportunity for the market.
Global irinotecan market report covers segmentation analysis of type and application. Based on type the market is sub segmented into irinotecan hydrochloride injection 40mg, irinotecan hydrochloride injection 100mg and others. Irinotecan Hydrochloride Injection 40mg is expected to be highest revenue generating segment and is expected to be fastest growing segment for the global Irinotecan drug market. Based on type the report is sub segmented into colon and rectal cancer. Rectal cancer is expected to dominate the global market owing to growing application of Irinotecan in the chemotherapy. Colon cancer is expected to fastest growing segment of cancer type due to growing prevalence of colon cancer.
North America accounted for the largest market share in terms of revenue for the Irinotecan market followed by Asia Pacific and Europe in 2017. High public and private funding for the development of new Irinotecan coupled with high prevalence colorectal cancer and presence of sound healthcare infrastructure contributes to the dominance of North America Irinotecan market during the forecast period. Moreover, Asia Pacific region is expected to be the fastest growing region in Irinotecan drug market during the forecast period. Factors such as increasing focus towards the development of biosimilars and growing healthcare expenditure are some of the major factors which contributes to the fastest growth rate of Asia Pacific Irinotecan market during the forecast period.
The major market players of the global Irinotecan market are Pfizer (USA), Teva (Israel), Taj Pharma (India), Takeda Pharmaceutical (Japan), Dr Reddy laboratories (India), West-Ward Pharmaceutical (USA) and Others. The global market for irinotecan market is highly consolidated with presence of few global players and a number of regional players. The companies in the market to increase their dominance are inclined towards new product development. For instance, in January 2017, Shire Pharma (Canada) announced that their product ONIVYDE irinotecan liposome has received approval for the treatment of metastatic adenocarcinoma of the pancreas. Similarly, in 2016 PharmaEngine (Taiwan) received Taiwan FDA approval for ONIVYDE and consecutively the drug developed by the company has received regulatory approval from US FDA and European Medical Agency.
1. Preface
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation
2. Executive Summary
2.1. Market Snapshot: Global Irinotecan Market
2.1.1. Global Irinotecan Market, by Application, 2018 (US$ Mn)
2.1.2. Global Irinotecan Market, by Type, 2018 (US$ Mn)
2.1.3. Global Irinotecan Market, by Geography, 2018 (US$ Mn)
3. Market Dynamics
3.1. Introduction
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Increasing cases of
3.2.1.2. Increased focus on cancer research
3.2.1.3. Benefits associated with the use of Irinotecan
3.2.2. Market Restraints
3.2.2.1. High cost of drug development
3.2.3. Market Opportunities
3.2.3.1. Growing healthcare expenditure
3.2.4. Market Challenges
3.2.4.1. Availability of alternate methods
3.3. Attractive Investment Proposition, by Geography, 2018
3.4. Market share of Key Players, 2018
3.5. Top five findings and strategic analysis
4. Global Irinotecan Market, by Type
4.1. Overview
4.1.1. Global Irinotecan Market Value Share, by Type, 2018 & 2026 (Value, %)
4.1.2. Global Irinotecan Market, by Type, 2019-2026 (US$ Mn)
4.2. Irinotecan Hydrochloride Injection 40mg
4.2.1. Global Irinotecan Market for Irinotecan Hydrochloride Injection 40mg, 2019-2026 (US$ Mn)
4.2.2. Global Irinotecan Market for Irinotecan Hydrochloride Injection 40mg, by Region 2019-2026 (US$ Mn)
4.3. Irinotecan Hydrochloride Injection 100mg
4.3.1. Global Irinotecan Market for Irinotecan Hydrochloride Injection 100mg, 2019-2026 (US$ Mn)
4.3.2. Global Irinotecan Market for Irinotecan Hydrochloride Injection 100mg, by Region 2019-2026 (US$ Mn)
4.4. Others
4.4.1. Global Irinotecan Market for Others, 2019-2026 (US$ Mn)
4.4.2. Global Irinotecan Market for Others, by Region 2019-2026 (US$ Mn)
5. Global Irinotecan Market, by Application
5.1. Overview
5.1.1. Global Irinotecan Market Value Share, by Application, 2018 & 2026 (Value, %)
5.1.2. Global Irinotecan Market, by Application, 2019-2026 (US$ Mn)
5.2. Colon Cancer
5.2.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
5.2.2. Global Irinotecan Market for Colon Cancer, 2019-2026 (US$ Mn)
5.2.3. Global Irinotecan Market for Colon Cancer, by Region 2019-2026 (US$ Mn)
5.3. Rectal Cancer
5.3.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
5.3.2. Global Irinotecan Market for Rectal Cancer, 2019-2026 (US$ Mn)
5.3.3. Global Irinotecan Market for Rectal Cancer, by Region 2019-2026 (US$ Mn)
6. North America Irinotecan Market Analysis
6.1. Overview
6.1.1. North America Irinotecan Market, by Application, 2019-2026 (US$ Mn)
6.1.2. North America Irinotecan Market, by Type, 2019-2026 (US$ Mn)
6.1.3. North America Irinotecan Market, by Country, 2019-2026 (US$ Mn)
6.1.3.1. United States
6.1.3.1.1. United States Irinotecan Market 2019 – 2026 (US$ Mn)
6.1.3.2. Canada
6.1.3.2.1. Canada Irinotecan Market 2019 – 2026 (US$ Mn)
7. Europe Irinotecan Market Analysis
7.1. Overview
7.1.1. Europe Irinotecan Market, by Application, 2019-2026 (US$ Mn)
7.1.2. Europe Irinotecan Market, by Type, 2019-2026 (US$ Mn)
7.1.3. Europe Irinotecan Market, by Country/Region, 2019-2026 (US$ Mn)
7.1.3.1. UK
7.1.3.1.1. UK Irinotecan Market 2019 – 2026 (US$ Mn)
7.1.3.2. Germany
7.1.3.2.1. Germany Irinotecan Market 2019 – 2026 (US$ Mn)
7.1.3.3. France
7.1.3.3.1. France Irinotecan Market 2019 – 2026 (US$ Mn)
7.1.3.4. Rest of Europe
7.1.3.4.1. Rest of Europe Irinotecan Market 2019 – 2026 (US$ Mn)
8. Asia Pacific Irinotecan Market Analysis
8.1. Overview
8.1.1. Asia Pacific Irinotecan Market, by Application, 2019-2026 (US$ Mn)
8.1.2. Asia Pacific Irinotecan Market, by Type, 2019-2026 (US$ Mn)
8.1.3. Asia Pacific Irinotecan Market, by Country/Region, 2019-2026 (US$ Mn)
8.1.3.1. China
8.1.3.1.1. China Irinotecan Market 2019 – 2026 (US$ Mn)
8.1.3.2. India
8.1.3.2.1. India Irinotecan Market 2019 – 2026 (US$ Mn)
8.1.3.3. Japan
8.1.3.3.1. Japan Irinotecan Market 2019 – 2026 (US$ Mn)
8.1.3.4. Rest of Asia Pacific
8.1.3.4.1. Rest of Asia Pacific Irinotecan Market 2019 – 2026 (US$ Mn)
9. Rest of the World Irinotecan Market Analysis
9.1. Overview
9.1.1. Rest of the World Irinotecan Market, by Application, 2019-2026 (US$ Mn)
9.1.2. Rest of the World Irinotecan Market, by Type, 2019-2026 (US$ Mn)
9.1.3. Rest of the World Irinotecan Market, by Country/Region, 2019 – 2026 (US$ Mn)
9.1.3.1. Latin America
9.1.3.1.1. Latin America Irinotecan Market 2019 – 2026 (US$ Mn)
9.1.3.2. MENA
9.1.3.2.1. MENA Irinotecan Market 2019 – 2026 (US$ Mn)
10. Company Profiles
10.1. Pfizer (USA)
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.3. Key Strategies
10.1.4. Key Conclusion
10.2. Teva (Israel)
10.2.1. Company Overview
10.2.2. Product Portfolio
10.2.3. Key Strategies
10.2.4. Key Conclusion
10.3. Actiza Pharmaceutical (India)
10.3.1. Company Overview
10.3.2. Product Portfolio
10.3.3. Key Strategies
10.3.4. Key Conclusion
10.4. Getwell Pharmaceutial (India)
10.4.1. Company Overview
10.4.2. Product Portfolio
10.4.3. Key Strategies
10.4.4. Key Conclusion
10.5. Taj Pharma (India)
10.5.1. Company Overview
10.5.2. Product Portfolio
10.5.3. Key Strategies
10.5.4. Key Conclusion
10.6. Salius (Canada)
10.6.1. Company Overview
10.6.2. Product Portfolio
10.6.3. Key Strategies
10.6.4. Key Conclusion
10.7. Cipla (India)
10.7.1. Company Overview
10.7.2. Product Portfolio
10.7.3. Key Strategies
10.7.4. Key Conclusion
10.8. Takeda Pharmaceutical (Japan)
10.8.1. Company Overview
10.8.2. Product Portfolio
10.8.3. Key Strategies
10.8.4. Key Conclusion
10.9. Scino Pharm (Taiwan)
10.9.1. Company Overview
10.9.2. Product Portfolio
10.9.3. Key Strategies
10.9.4. Key Conclusion
10.10. Dr Reddy laboratories (India)
10.10.1. Company Overview
10.10.2. Product Portfolio
10.10.3. Key Strategies
10.10.4. Key Conclusion
1. Global Irinotecan Market, by Type, 2019-2026 (US$ Mn)
2. Global Irinotecan Market for Irinotecan Hydrochloride Injection 40mg, by Region 2019-2026 (US$ Mn)
3. Global Irinotecan Market for Irinotecan Hydrochloride Injection 100mg, by Region 2019-2026 (US$ Mn)
4. Global Irinotecan Market for Others, by Region 2019-2026 (US$ Mn)
5. Global Irinotecan Market, by Application, 2019-2026 (US$ Mn)
6. Global Irinotecan Market for Colon Cancer, by Region 2019-2026 (US$ Mn)
7. Global Irinotecan Market for Rectal Cancer, by Region 2019-2026 (US$ Mn)
8. Global Irinotecan Market, by Geography, 2019-2026 (US$ Mn)
9. North America Irinotecan Market, by Type, 2019-2026 (US$ Mn)
10. North America Irinotecan Market, by Application, 2019-2026 (US$ Mn)
11. North America Irinotecan Market, by Country, 2019-2026 (US$ Mn)
12. Europe Irinotecan Market, by Type, 2019-2026 (US$ Mn)
13. Europe Irinotecan Market, by Application, 2019-2026 (US$ Mn)
14. Europe Irinotecan Market, by Country/Region, 2019-2026 (US$ Mn)
15. Asia Pacific Irinotecan Market, by Type, 2019-2026 (US$ Mn)
16. Asia Pacific Irinotecan Market, by Application, 2019-2026 (US$ Mn) )
17. Asia Pacific Irinotecan Market, by Country/Region, 2019-2026 (US$ Mn)
18. Rest of the World Irinotecan Market, by Type, 2019-2026 (US$ Mn)
19. Rest of the World Irinotecan Market, by Application, 2019-2026 (US$ Mn)
20. Rest of the World Irinotecan Market, by Country/Region, 2019 – 2026 (US$ Mn)
1. Global Irinotecan Market, by Type, 2018 (US$ Mn)
2. Global Irinotecan Market, by Application, 2018 (US$ Mn)
3. Global Irinotecan Market, by Geography, 2018 (US$ Mn)
4. Global Irinotecan Market Value Share, by Type, 2018 & 2026 (Value, %)
5. Global Irinotecan Market for Irinotecan Hydrochloride Injection 40mg, 2019-2026 (US$ Mn)
6. Global Irinotecan Market for Irinotecan Hydrochloride Injection 100mg, 2019-2026 (US$ Mn)
7. Global Irinotecan Market Value Share, by Application, 2018 & 2026 (Value, %)
8. Global Irinotecan Market for Colon Cancer, 2019-2026 (US$ Mn)
9. Global Irinotecan Market for Rectal Cancer, 2019-2026 (US$ Mn)
10. United States Irinotecan Market 2019 – 2026 (US$ Mn)
11. Canada Irinotecan Market 2019 – 2026 (US$ Mn)
12. UK Irinotecan Market 2019 – 2026 (US$ Mn)
13. Germany Irinotecan Market 2019 – 2026 (US$ Mn)
14. France Irinotecan Market 2019 – 2026 (US$ Mn)
15. Rest of Europe Irinotecan Market 2019 – 2026 (US$ Mn)
16. China Irinotecan Market 2019 – 2026 (US$ Mn)
17. India Irinotecan Market 2019 – 2026 (US$ Mn)
18. Japan Irinotecan Market 2019 – 2026 (US$ Mn)
19. Rest of Asia Pacific Irinotecan Market 2019 – 2026 (US$ Mn)
20. Latin America Irinotecan Market 2019 – 2026 (US$ Mn)
21. MENA Irinotecan Market 2019 – 2026 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)